A Single-centre, Open-label, Non-controlled, Exploratory Safety and Efficacy Clinical Trial of GT08 in Volunteers and Patients Who Are Infected With Helicobacter Pylori.
Phase of Trial: Phase I/II
Latest Information Update: 30 May 2014
At a glance
- Drugs GT 08 (Primary)
- Indications Helicobacter pylori infections
- Focus Therapeutic Use
- Sponsors Synergy Pharmaceuticals Inc
- 01 Apr 2014 Status changed from recruiting to discontinued as reported by ClinicalTrials.gov record.
- 09 Sep 2010 Actual initiation date added to 1 May 2010 as reported by ClinicalTrials.gov.
- 09 Sep 2010 Status changed from not yet recruiting to recruiting as reported by ClinicalTrials.gov.